Spherical Nucleic Acid Nanoparticles: Therapeutic Potential Chintan H. KapadiaJilian R. MelamedEmily S. Day Leading Article 29 June 2018 Pages: 297 - 309
Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy Sarah YentzDavid Smith Leading Article 06 July 2018 Pages: 311 - 317
The End of Phase 3 Clinical Trials in Biosimilars Development? Francois-Xavier Frapaise Current Opinion 26 June 2018 Pages: 319 - 324
Determination of Similarity Margin in Comparative Clinical Studies to Support the Development of Biosimilar Products of Neupogen® (Filgrastim, Granulocyte Colony-Stimulating Factor [G-CSF]) Lei NieDonna PrzepiorkaThomas E. Gwise Current Opinion 13 July 2018 Pages: 325 - 330
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease Gerolamo BevivinoSilvia SeddaGiovanni Monteleone Review Article 08 June 2018 Pages: 331 - 338
Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies Roger B. DoddTrevor WilkinsonDarren J. Schofield Review Article 23 June 2018 Pages: 339 - 355
Regenerative Therapies for Parkinson’s Disease: An Update Thomas B. StokerRoger A. Barker Review Article 19 July 2018 Pages: 357 - 366
Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study Giovanna StoppaCarmen D’AmoreESAVIEW Study Group Original Research Article Open access 20 July 2018 Pages: 367 - 375
Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS) Ariane G. S. AraujoHelena H. L. BorbaAstrid Wiens Original Research Article 05 June 2018 Pages: 377 - 390
